Sen. Chuck Grassley requested CMS investigate whether nursing home patients were being given antipsychotic drugs for off-label uses. The findings are shocking. CMS found that 88 percent of the powerful antipsychotic drugs being prescribed to nursing home residents with dementia were for uses that have not been approved by the Food and Drug Administration. Click here Sen. Grassley's press release. Click here for his letter to CMS.
Here is the GAO report: